title: Phototherapy rash in newborn infants: does it differ between conventional and light emitting diode phototherapy?
abstract: Data comparing the cutaneous side effects of light emitting diode (LED) phototherapy (LP) and conventional phototherapy (CP) devices in jaundiced newborn infants are very limited. We investigated the incidence and extent of skin eruptions caused by different phototherapy devices in preterm infants who are more prone to neonatal jaundice. This prospective, randomized controlled trial was conducted in the neonatal intensive care unit (NICU) of Hacettepe University Ihsan Dogramaci Childrens' Hospital in Ankara, Turkey. Preterm infants without skin lesions before and requiring phototherapy in the first week of life were included in the study. The infants were randomly assigned to receive CP or LP and were monitored closely for skin eruptions during phototherapy. Fifty-eight infants were included in the study: 25 (43.1%) received CP while 33 (56.9%) received LP. The duration of phototherapy was similar in the two groups (30.4 ± 9.6 hours and 31.8 ± 15.6 hours, respectively). Baseline and control bilirubin levels were similar for the two groups (p = 0.101 and p = 0.105, respectively). The frequency of skin eruptions was 36% in the CP group and 33% in the LP group (p = 0.83). The skin eruptions were macules in 13 (22.4%), papules in 5 (8.6%), and maculopapular rashes in 2 (3.4%) infants.There were no differences in the incidence and extent of skin eruptions in preterm infants who received CP or LP.
authors.affiliation: Division of Neonatology, Department of Pediatrics, Faculty of Medicine, Hacettepe University, Ankara, Turkey.
authors.forename: Ozge
authors.initials: O
authors.lastname: Surmeli-Onay
authors.forename: Ayse
authors.initials: A
authors.lastname: Korkmaz
authors.forename: Sule
authors.initials: S
authors.lastname: Yigit
authors.forename: Murat
authors.initials: M
authors.lastname: Yurdakok
mesh_terms: D001663:Bilirubin / Q000097:blood; D005076:Exanthema / Q000453:epidemiology / Q000209:etiology*; D005260:Female; D005865:Gestational Age; D006801:Humans; D015994:Incidence; D007231:Infant, Newborn; D007234:Infant, Premature; D015931:Intensive Care, Neonatal / Q000379:methods*; D007567:Jaundice, Neonatal / Q000378:metabolism / Q000628:therapy*; D008297:Male; D010789:Phototherapy / Q000009:adverse effects* / Q000379:methods*; D011446:Prospective Studies
chemical_list: D001663:Bilirubin